Intelligence Platform

Patents

Browse 111 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10314850

Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucoc

Corcept Therapeutics Incorporated · Granted Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 06 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272074

Inhibitors of glucocorticoid receptor translocation

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10238659

Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagoni

Corcept Therapeutics Incorporated · Granted Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10231983

Use of ACTH in assessment and prophylactic treatment of hypokalemia associated with glucoc

Corcept Therapeutics Incorporated · Granted Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10213414

Glucocorticoid receptor modulators to treat pancreatic cancer

Corcept Therapeutics Incorporated · Granted Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10195214

Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors

Corcept Therapeutics Incorporated · Granted Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10117852

Glucocorticoid receptor modulators to treat pancreatic cancer

Corcept Therapeutics Incorporated · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10047082

Octahydro fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Aug 14 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9980976

Use of REDD1 inhibitors to dissociate therapeutic and adverse atrophogenic effects of gluc

Northwestern University · Granted Tue May 29 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9956216

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue May 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9943505

Glucocorticoid receptor modulators to treat pancreatic cancer

Corcept Therapeutics Incorporated · Granted Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707223

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9321736

Pyrimidine cyclohexyl glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Apr 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273047

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9217026

Method of inactivating a glucocorticoid receptor gene in an isolated cell

Sangamo Biosciences, Inc. · Granted Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8940705

Method of treating disease and selectively modulating transcriptional regulation by a gluc

The Regents of the University of California · Granted Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8921348

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders

Corcept Therapeutics Incorporated · Granted Tue Dec 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8906917

Pyrimidine cyclohexyl glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859774

Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8829024

Combination steroid and glucocorticoid receptor antagonist therapy

Corcept Therapeutics Incorporated · Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741880

Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

Corcept Therapeutics Incorporated · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8685973

Pyrimidine cyclohexyl glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598149

Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders

Corcept Therapeutics Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557839

Fused ring azadecalin glucocorticoid receptor modulators

Corcept Therapeutics Incorporated · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted